Every evening on Phillip Island, more than 700,000 visitors a year watch little penguins — barely a foot tall, the smallest of their kind — emerge from the surf and waddle up the beach to their burrows. It’s one of Australia’s most beloved wildlife spectacles.
Now, an invisible threat is moving toward those colonies. H5N1 bird flu, highly infectious and capable of killing birds suddenly and in large numbers, has already claimed at least one penguin on the island. Protecting the rest will require a logistical undertaking wildlife managers have never attempted at this scale.
The world’s smallest penguin faces a very large threat
Little penguins are easy to underestimate. Standing just 30 centimeters tall and weighing around 1.5 kilograms, they’re the smallest penguin species on Earth, living along Australia’s southern coast — from Western Australia to New South Wales — as well as Tasmania and New Zealand.
The colonies at Phillip Island and St. Kilda are especially large, housing around 40,000 birds. That density is exactly what makes them so vulnerable. H5N1 spreads fast when birds live close together, and the virus can kill suddenly and in large numbers. One penguin at Phillip Island has already died from it.
This threat lands on top of pressures already straining the species: invasive predators like cats and foxes, artificial light, road traffic, and overfishing. Warming oceans are shrinking fish populations too. A tourist attraction in Bicheno, Tasmania, recently had to close temporarily after adults failed to return to shore — a situation ecologists linked to a sudden spike in sea temperature.
An unprecedented vaccination campaign takes shape
Victoria’s wildlife officers are now planning to catch and vaccinate more than 5,000 little penguins at Phillip Island and St. Kilda. The state government describes it as the largest wild bird vaccination program ever launched, and no comparable effort exists to measure it against.
Little penguins happen to be among the more manageable wild birds for this kind of work. They’re flightless, nest in colonies, and reliably return to the same burrow each night. That predictability gives wildlife officers a realistic window to catch and handle them — something nearly impossible with most other wild bird species.
The vaccine itself is relatively new to this context. Federal authorization for its use with priority native bird species came only recently, and it hadn’t been tested on native Australian birds — let alone little penguins — until just before this campaign began.
Parallel efforts are underway elsewhere. New Zealand is vaccinating around 300 captive individuals from five species, including the critically endangered kākāpō and the endangered South Island takahē. In Australia, endangered captive birds in zoos — among them the regent honeyeater, the orange-bellied parrot, and black cockatoos — are also receiving the vaccine.
Why two doses — and two captures — are unavoidable
The H5N1 vaccine requires two shots. That single requirement shapes the entire logistical challenge of the program.
The first dose introduces the immune system to inactivated viral particles. The body detects them as foreign, produces antibodies, and generates memory B cells — specialized cells that retain a record of the virus’s protein structure, ready to act if they encounter it again.
The second shot, given weeks later, triggers those memory B cells to respond rapidly, producing a sharp surge in antibody levels. Higher concentrations improve the odds of neutralizing the virus before it can establish an infection. If that process sounds familiar, it’s the same basic mechanism behind the booster shots humans receive for a range of vaccines. The biology is consistent across species — but catching a wild penguin twice, weeks apart, is the central operational challenge wildlife managers now have to solve.
What vaccination can — and cannot — do
Vaccination reduces risk. It doesn’t eliminate it. Not every penguin can be reached, and even vaccinated birds aren’t guaranteed full protection. Wildlife managers are working with a tool that helps — not one that solves the problem completely.
H5N1 also continues to evolve. Like COVID-19, the virus adapts over time to outmaneuver host immune systems, which means the current vaccine may not remain effective indefinitely. New strains may eventually require new formulations.
Climate change adds another layer. Environmental stress weakens wildlife populations and can accelerate how viruses adapt to new hosts — and these pressures don’t operate in isolation. They compound each other.
What’s happening in Victoria right now is best understood as one essential component of a longer conservation effort. The vaccination program buys time and reduces harm. But watching how it performs — how many birds are successfully reached, how well the vaccine holds, how the virus continues to move — will shape what wildlife managers do next, in Australia and around the world.
Read the whole thing?
Get the week's signal, not the noise
Our sharpest reporting on energy, climate and nature — free, once a week.
